欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Fulphila	Human	pegfilgrastim	pegfilgrastim	EMEA/H/C/004915	Biosimilar Collaborations Ireland Limited	2018/11/20	Authorised
Emgality	Human	galcanezumab	Galcanezumab	EMEA/H/C/004648	Eli Lilly Nederland B.V.	2018/11/14	Authorised
Symkevi	Human	tezacaftor;ivacaftor	tezacaftor;ivacaftor	EMEA/H/C/004682	Vertex Pharmaceuticals (Ireland) Limited	2018/10/31	Authorised
Gefitinib Mylan	Human	gefitinib	gefitinib	EMEA/H/C/004826	Mylan Pharmaceuticals Limited	2018/09/27	Withdrawn
Verzenios	Human	abemaciclib	abemaciclib	EMEA/H/C/004302	Eli Lilly Nederland B.V.	2018/09/26	Authorised
Imfinzi	Human	durvalumab	durvalumab	EMEA/H/C/004771	AstraZeneca AB	2018/09/21	Authorised
Pelgraz	Human	pegfilgrastim	pegfilgrastim	EMEA/H/C/003961	Accord Healthcare S.L.U.	2018/09/21	Authorised
Udenyca	Human	pegfilgrastim	pegfilgrastim	EMEA/H/C/004413	ERA Consulting GmbH	2018/09/21	Withdrawn
Xerava	Human	eravacycline	eravacycline	EMEA/H/C/004237	PAION Pharma GmbH	2018/09/20	Authorised
Slenyto	Human	melatonin	melatonin	EMEA/H/C/004425	RAD Neurim Pharmaceuticals EEC SARL	2018/09/20	Authorised
Mektovi	Human	binimetinib	binimetinib	EMEA/H/C/004579	Pierre Fabre Medicament	2018/09/20	Authorised
Kigabeq	Human	vigabatrin	vigabatrin	EMEA/H/C/004534	ORPHELIA Pharma	2018/09/20	Authorised
Lenalidomide Accord	Human	lenalidomide	lenalidomide	EMEA/H/C/004857	Accord Healthcare S.L.U.	2018/09/20	Authorised
Braftovi	Human	encorafenib	Encorafenib	EMEA/H/C/004580	Pierre Fabre Medicament	2018/09/19	Authorised
Deferiprone Lipomed	Human	deferiprone	Deferiprone	EMEA/H/C/004710	Lipomed GmbH	2018/09/19	Authorised
Ilumetri	Human	tildrakizumab	tildrakizumab	EMEA/H/C/004514	Almirall, S.A.	2018/09/17	Authorised
Hulio	Human	adalimumab	adalimumab	EMEA/H/C/004429	Biosimilar Collaborations Ireland Limited	2018/09/17	Authorised
Veyvondi	Human	vonicog alfa	vonicog alfa	EMEA/H/C/004454	Baxalta Innovations GmbH	2018/08/31	Authorised
Nerlynx	Human	neratinib	neratinib	EMEA/H/C/004030	Pierre Fabre Medicament	2018/08/31	Authorised
Cablivi	Human	caplacizumab	Caplacizumab	EMEA/H/C/004426	Ablynx NV	2018/08/30	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-